ETAP-Lab - Preclinical Efficacy CRO

ETAP-Lab provides preclinical models and services in the fields of Dermatology, Stroke and Neurodegenerative Diseases. The company has strong expertise in the field of Dermatology research and offers a large portfolio of original in vivo rodent models such as chronic skin inflammation, ischemic ulceration, psoriasis, hyperkeratosis, wound healing, atopic dermatitis, actinic keratosis, skin cancer... ETAP-Lab is also leader in the field of preclinical stroke research with a unique model portfolio consisting of innovative and translational models proposed under the brand Strok@lliance. With more than 2 decades of experience, ETAP-Lab has become a best-in-class service provider for top tier Pharma, Medical...

Toxicology,dermatology,neurosciences,stroke,preclinical pharmacology,rodent model,in vitro models,animal model,inflammatory diseases,neurodegenerative diseases,preclinical efficacy,neurology,cardiorespiratory,in vivo drug efficacy study,customized study,medium throughput,parkinson,and alzheimer

Etap-lab - preclinical efficacy cro operates in the Research services industry.

Etap-lab - preclinical efficacy cro's revenue is 11m - 100m

Etap-lab - preclinical efficacy cro has 11 - 50 employees.